The real-world impact of dosing of methadone and buprenorphine in retention on opioid agonist therapies in Ukraine.

Scott O FarnumIuliia MakarenkoLynn MaddenAlyona MazhnayaRuthanne MarcusTanya ProkhorovaMartha J BojkoJulia RozanovaSergii DvoriakZahedsul IslamFrederick L Altice

Published in: Addiction (Abingdon, England) (2020)

Higher dosages of opioid agonist therapies, especially for methadone maintenance treatment patients, appear to be associated with higher levels of treatment retention in Ukraine.

Keyphrases

chronic pain
end stage renal disease
pain management
newly diagnosed
ejection fraction
peritoneal dialysis
combination therapy